• If you are wondering whether IMAX shares still offer value after a strong run, this article walks through what the current price may be implying about the business.
• The stock closed at US$36.83, with a 7 day return of a 2.7% decline, a 30 day return of 6.4%, a year to date return of 2.2%, and a 1 year return of 39.6%, alongside a 3 year return of 99.7% and a 5 year return of 71.6%.
• These moves sit against a backdrop of ongoing interest in large format cinema and premium theatrical experiences, which keeps IMAX on many investors' watchlists. Broader industry headlines around film release schedules, box office trends, and the role of cinemas in studio distribution plans help frame how investors are thinking about the company.
• IMAX currently has a valuation score of 3 out of 6, which reflects the number of checks where the stock screens as undervalued. Next, we will look at what different valuation methods say about that number, before finishing with a way to tie them all together more effectively.

Approach 1: IMAX Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s value so you can compare that estimate to the current share price.

For IMAX, the model used is a 2 Stage Free Cash Flow to Equity approach. The company’s last twelve month free cash flow is reported at $68.9 million. Analyst based projections and subsequent extrapolations by Simply Wall St suggest free cash flow building over time, with one of the later specific projections at $260.3 million in 2035, expressed in today’s dollars through discounting.

When you add up all these discounted cash flows, the model arrives at an estimated intrinsic value of US$61.86 per share. Compared to the recent share price of US$36.83, this implies the stock is about 40.5% undervalued based on these assumptions and projections.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests IMAX is undervalued by 40.5%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: IMAX Price vs Earnings

For profitable companies, the P/E ratio is a useful shorthand because it links what you pay per share directly to the earnings the business is producing today. It lets you compare how the market is pricing one stream of earnings against another.

What counts as a “normal” or “fair” P/E depends on how the market views a company’s growth prospects and risk. Higher expected growth or lower perceived risk can justify a higher multiple, while lower growth or higher risk usually points to a lower one.

IMAX currently trades on a P/E of 50.11x, compared with the Entertainment industry average of about 30.01x and a peer group average of 65.00x. Simply Wall St’s Fair Ratio for IMAX is 22.53x, which is its proprietary estimate of what the P/E might be given factors such as earnings growth, profit margins, industry, market cap and company specific risks.

This Fair Ratio aims to be more tailored than a simple peer or industry comparison, because it adjusts for differences in business quality and risk profile rather than assuming all companies deserve similar multiples. On this basis, IMAX’s current P/E of 50.11x sits above the Fair Ratio of 22.53x, which points to the shares screening as expensive on this metric.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 22 top founder-led companies.

Upgrade Your Decision Making: Choose your IMAX Narrative

Earlier we mentioned that there is an even better way to understand valuation. On Simply Wall St’s Community page you can use Narratives, where you write a simple story about IMAX that captures your view on its future revenue, earnings and margins, link that story to a forecast and a Fair Value, and then compare that Fair Value with today’s price to decide whether the stock looks attractive or stretched. The Narrative updates as new news or earnings arrive. For example, one IMAX Narrative might lean toward the higher Fair Value of about US$47.00 based on stronger premium format demand and content partnerships. Another might sit closer to the lower Fair Value of roughly US$22.04 based on concerns about at home entertainment and box office volatility. This gives you a clear, numbers backed way to see where your own view fits on that spectrum.

For IMAX however we'll make it really easy for you with previews of two leading IMAX Narratives:

🐂 IMAX Bull Case

Fair Value: US$47.00 per share

Gap to Fair Value: about 21.6% below this narrative fair value at the recent US$36.83 share price

Assumed Revenue Growth: 11.12% per year

• Backers of this case focus on IMAX's position in premium content and network expansion, pointing to opportunities in recurring box office revenue, new system installations, and a growing backlog of signed deals.
• They expect live sports, concerts, and other alternative content to build new revenue streams on top of blockbusters, while pricing power in premium experiences supports higher margins.
• This camp thinks the reaffirmed US$47.00 target reflects the potential for stronger earnings and free cash flow than many models currently assume, even after factoring in sector risks such as development costs and competition for premium content.

🐻 IMAX Bear Case

Fair Value: US$22.04 per share

Gap to Fair Value: about 67.1% above this narrative fair value at the recent US$36.83 share price

Assumed Revenue Growth: 6.63% per year

• The cautious view leans on the idea that at home entertainment is narrowing IMAX's experiential edge, which could limit long run cinema attendance and box office potential.
• It highlights reliance on blockbuster releases, possible saturation in developed markets, and competition from other premium large formats as sources of earnings volatility.
• Supporters of this case see the US$22.04 fair value as more in line with moderate revenue growth assumptions and a lower future P/E if market expectations around cinema going prove too optimistic.

If you want to go a level deeper than this snapshot, the full Narratives on Simply Wall St let you adjust the revenue growth, margins, and P/E assumptions yourself, then see how your personal fair value for IMAX compares with today's price.

Do you think there's more to the story for IMAX? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.